表紙
市場調査レポート

Beijing Tiantan Biological Products Co., Ltd.:製品パイプライン分析

Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 306089
出版日 ページ情報 英文 21 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
Beijing Tiantan Biological Products Co., Ltd.:製品パイプライン分析 Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015
出版日: 2015年10月30日 ページ情報: 英文 21 Pages
概要

Beijing Tiantan Biological Products Co., Ltd.は、ウイルスおよび細菌感染症向けのワクチンを研究、開発、製造、販売するバイオテクノロジー企業です。

当レポートでは、Beijing Tiantan Biological Products Co., Ltd.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Beijing Tiantan Biological Products Co., Ltd.の基本情報

Beijing Tiantan Biological Products Co., Ltd.の概要

  • 主要情報
  • 企業情報

Beijing Tiantan Biological Products Co., Ltd.:R&Dの概要

  • 主な治療範囲

Beijing Tiantan Biological Products Co., Ltd.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • 併用療法モダリティ

Beijing Tiantan Biological Products Co., Ltd.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Beijing Tiantan Biological Products Co., Ltd.:薬剤プロファイル

Beijing Tiantan Biological Products Co., Ltd.:パイプライン分析

  • 分子タイプ別

Beijing Tiantan Biological Products Co., Ltd.:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07718CDB

Summary

Global Markets Direct's, 'Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Beijing Tiantan Biological Products Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Beijing Tiantan Biological Products Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Beijing Tiantan Biological Products Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Beijing Tiantan Biological Products Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Beijing Tiantan Biological Products Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Beijing Tiantan Biological Products Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Beijing Tiantan Biological Products Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Beijing Tiantan Biological Products Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Beijing Tiantan Biological Products Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Beijing Tiantan Biological Products Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Beijing Tiantan Biological Products Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Beijing Tiantan Biological Products Co., Ltd. Snapshot
    • Beijing Tiantan Biological Products Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Beijing Tiantan Biological Products Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Products Glance
    • Beijing Tiantan Biological Products Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Beijing Tiantan Biological Products Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Beijing Tiantan Biological Products Co., Ltd. - Drug Profiles
    • meningococcal polysaccharide [serotypes A, C, Y, W-135] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • poliomyelitis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • measles + mumps + rubella + varicella vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • meningococcal [serotypes A and C] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pertussis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Analysis
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Products by Molecule Type
  • Beijing Tiantan Biological Products Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Beijing Tiantan Biological Products Co., Ltd., Key Information
  • Beijing Tiantan Biological Products Co., Ltd., Key Facts
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Indication, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Stage of Development, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Combination Treatment Modalities in Pipeline, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Phase I, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Preclinical, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Molecule Type, 2015
  • Beijing Tiantan Biological Products Co., Ltd., Subsidiaries

List of Figures

  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Stage of Development, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top